Search results for: 'research area epigenetics hypoxia inducible factors'
-
A2477 Tyrphostin AG 12961 CitationTarget: PDGFRSummary: PDGFR inhibitor,selective and ATP-competitive -
A3843 SU 5402Target: VEGFR|PDGFR|FGFRSummary: VEGFR2/FGFR/PDGFR/EGFR inhibitor
-
A3022 Pazopanib (GW-786034)Target: CSF-1R|VEGFR|PDGFR|c-Kit|FGFRSummary: VEGFR/PDGFR/FGFR inhibitor
-
A8370 Axitinib (AG 013736)1 CitationTarget: VEGFR|PDGFR|c-KitSummary: VEGFR1/ c-Kit inhibitor
-
A8252 Nintedanib (BIBF 1120)3 CitationTarget: VEGFR|PDGFR|FGFRSummary: VEGFR/PDGFR/FGFR inhibitor
-
A2942 Masitinib (AB1010)Target: PDGFR|c-Kit|LynSummary: Tyrosine kinase inhibitor, potent and selective
-
A2024 PD168393Target: PDGFR|FGFR|EGFR|PKC|insulinSummary: EGFR inhibitor
-
B5953 Dovitinib (TKI258) LactateTarget: CSF-1R|FLT3|VEGFR|PDGFR|c-Kit|FGFRSummary: Oral tyrosine kinase inhibitor (TKI) against FGFR1–3, VEGFR1–3, and platelet-derived growth factor receptor (PDGFR).